With more than 65 years of experience in delivering life-changing science, Lantheus is committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions that enable clinicians to Find, Fight and Follow disease. Lantheus (NASDAQ LNTH) is headquartered in Massachusetts and has offices in New Jersey, Canada and Sweden. For more information, visit www.lantheus.com
Ticker:
LNTH
Exchange:
NASDAQ
Company Type:
Publicly Traded Company
Company Website:
Company HQ State:
MA
Company HQ Country:
United States
Year Founded:
1956
Main Therapeutic Focus:
Oncology
Lead Product in Development:
PNT2002
Development Phase of Primary Product:
Phase III
Number Of Unlicensed Products (For Which You Are Seeking Partners):
4
Speaker
